[Interferon: IntronA, Roferon].
Gaudy-Marqueste
C
C
Service de Dermatologie Assistance Publique, Hôpitaux de Marseille, Université de Méditerranée Aix-Marseille II, CHU Sainte-Marguerite, 270, boulevard Sainte-Marguerite, 13009 Marseille. Caroline.Gaudy@mail.ap-hm.fr
Grob
J-J
JJ
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012871:Skin Diseases / Q000188:drug therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins